JP2009500314A5 - - Google Patents

Download PDF

Info

Publication number
JP2009500314A5
JP2009500314A5 JP2008518963A JP2008518963A JP2009500314A5 JP 2009500314 A5 JP2009500314 A5 JP 2009500314A5 JP 2008518963 A JP2008518963 A JP 2008518963A JP 2008518963 A JP2008518963 A JP 2008518963A JP 2009500314 A5 JP2009500314 A5 JP 2009500314A5
Authority
JP
Japan
Prior art keywords
agent
agents
peptide
agent according
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008518963A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500314A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2006/002390 external-priority patent/WO2007000601A2/en
Publication of JP2009500314A publication Critical patent/JP2009500314A/ja
Publication of JP2009500314A5 publication Critical patent/JP2009500314A5/ja
Pending legal-status Critical Current

Links

JP2008518963A 2005-06-29 2006-06-28 遺伝子調節 Pending JP2009500314A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69513605P 2005-06-29 2005-06-29
PCT/GB2006/002390 WO2007000601A2 (en) 2005-06-29 2006-06-28 Gene regulation

Publications (2)

Publication Number Publication Date
JP2009500314A JP2009500314A (ja) 2009-01-08
JP2009500314A5 true JP2009500314A5 (enExample) 2009-08-20

Family

ID=37595498

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008518963A Pending JP2009500314A (ja) 2005-06-29 2006-06-28 遺伝子調節

Country Status (5)

Country Link
US (1) US20090286738A1 (enExample)
EP (1) EP1909811B1 (enExample)
JP (1) JP2009500314A (enExample)
AT (1) ATE543504T1 (enExample)
WO (1) WO2007000601A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2748009A1 (en) * 2008-12-23 2010-07-01 Vivoscript, Inc. Compositions and methods for re-programming cells without genetic modification
GB2543550A (en) * 2015-10-21 2017-04-26 Hox Therapeutics Ltd Peptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69736351T4 (de) * 1996-05-08 2009-07-23 Cyclacel Ltd. Methoden und mittel zur hemmung der cdk4-aktivität
CA2337574C (en) * 2000-02-23 2013-01-22 Institut De Recherches Cliniques De Montreal/Ircm Hematopoietic stem cell expansion enhancing factor and method of use
GB0229151D0 (en) * 2002-12-13 2003-01-15 St Georges Entpr Ltd Product and method

Similar Documents

Publication Publication Date Title
CN112739366B (zh) κ阿片受体激动剂的口服配制品
JP2010536714A5 (enExample)
IL308807B1 (en) Combination therapy for cancer treatment
JP7175506B2 (ja) 低血圧治療のための単独または併用使用されるアンギオテンシンｉｉ
JP2022514255A5 (enExample)
JP2004521108A5 (enExample)
JP2012115277A5 (enExample)
JP7606966B2 (ja) ミトコンドリア病を標的とするアナログ
JP2004536077A5 (enExample)
JPWO2019107530A5 (enExample)
EP3276004A3 (en) Methods for treating chronic kidney disease
JP2012530060A5 (enExample)
JP2006501165A5 (enExample)
JP2007518818A5 (enExample)
JP2011518176A5 (enExample)
SK145993A3 (en) Antiretroviral hydrazine derivatives
CN113544138A (zh) 线粒体靶向肽
Peng et al. Synthesis and activity of tumor-homing peptide iRGD and histone deacetylase inhibitor valproic acid conjugate
JP2015514771A5 (enExample)
ES2744474T3 (es) Fragmentos polipeptídicos de168A-T2 y composiciones que los comprenden para uso en el tratamiento del cáncer
JP2018533570A5 (enExample)
CN115697354A (zh) 用于治疗sars-cov-2感染的组合物和方法
JP2008508363A5 (enExample)
CA2634902A1 (en) Anticancer agent comprising a peptide
US20210269482A1 (en) Peptoid-peptide macrocycles, pharmaceutical compositions and methods of using the same